Menu
Hall Render asked HRSA Administrator Thomas Engels and HHS Inspector General March Bell to open an investigation into Lilly’s new 340B in-house claims data policy.

Provider Law Firm Urges HHS IG Investigation into Lilly’s 340B Data Demands

Luke Zarzecki, National Correspondent 340B Report Views
A law firm representing 340B providers urged federal regulators Wednesday to investigate Eli Lilly’s new 340B in-house pharmacy claims data [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Federal Appeals Court Holds Oral Arguments on Maine, Rhode Island 340B Contract Pharmacy Laws

Federal Judge Tosses AbbVie Challenge to Mississippi’s 340B Contract Pharmacy Law

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live